Skip to main content
Fig. 1 | Parasites & Vectors

Fig. 1

From: Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) in the prevention of feline Aelurostrongylus abstrusus infection evaluated in a multi-diagnostic approach

Fig. 1

Overview on the design of the confirmation study to assess the preventive efficacy of Bravecto® Plus spot-on solution (IVP, minimum recommended dose of 40 mg fluralaner and 2.0 mg moxidectin/kg body weight; G1, G2, G3). The control group (G4) received a placebo (0.9% saline solution), as did the treatment groups on the study days when they did not receive IVP treatment. CT: computed tomography; L3: third-stage larvae; SD: study day

Back to article page

Parasites & Vectors

ISSN: 1756-3305

Contact us